Suchergebnisse - "Personeni, Nicola"

PubPharm (136)

11

Real-World Data on Ivosidenib in Patients with Previously Treated Isocitrate Dehydrogenase 1-Mutated Intrahepatic Cholangiocarcinomas: An Early Exploratory Analysis

enthalten in: Targeted oncology | 2022

von Rimini, M. | Burgio, V. | Antonuzzo, L. | +13

12

Real-World Data on Ivosidenib in Patients with Previously Treated Isocitrate Dehydrogenase 1-Mutated Intrahepatic Cholangiocarcinomas: An Early Exploratory Analysis

enthalten in: Targeted oncology | 2022

von Rimini, M. | Burgio, V. | Antonuzzo, L. | +13

13

Real-World Data on Ivosidenib in Patients with Previously Treated Isocitrate Dehydrogenase 1-Mutated Intrahepatic Cholangiocarcinomas: An Early Exploratory Analysis

enthalten in: Targeted oncology | 2022

von Rimini, M. | Burgio, V. | Antonuzzo, L. | +13

14

Multidisciplinary Tumor Board in the Management of Patients with Colorectal Liver Metastases : A Single-Center Review of 847 Patients

enthalten in: Cancers | 2022

von Milana, F. | Famularo, S. | Luberto, A. | +12

15

Patterns and outcomes of subsequent therapy after immune checkpoint inhibitor discontinuation in HCC

enthalten in: Hepatology communications | 2022

von Sharma, R. | Pillai, A. | Marron, T. | +26

16

Temozolomide Treatment Alters Mismatch Repair and Boosts Mutational Burden in Tumor and Blood of Colorectal Cancer Patients

enthalten in: Cancer discovery | 2022

von Crisafulli, G. | Sartore-Bianchi, A. | Lazzari, L. | +23

CommentIn: Cancer Discov. 2022 Jul 6;12(7):1612-1614. - PMID 35791694

17

Cabozantinib plus atezolizumab for the treatment of advanced hepatocellular carcinoma : shedding light on the preclinical rationale and clinical trials

enthalten in: Expert opinion on investigational drugs | 2022

von Cammarota, A. | Zanuso, V. | D'Alessio, A. | +3

18

The dual checkpoint blockade in unresectable hepatocellular carcinoma : opportunities emerging in clinical trials

enthalten in: Expert opinion on investigational drugs | 2022

von Cammarota, A. | Zanuso, V. | D'Alessio, A. | +4

19

Exploring novel avenues for neoadjuvant treatment of hepatocellular carcinoma

enthalten in: The lancet. Gastroenterology & hepatology | 2022

von Personeni, N. | Rimassa, L.

CommentOn: Lancet Gastroenterol Hepatol. 2022 Mar;7(3):208-218. - PMID 35065057

20

Prognosis of patients with hepatocellular carcinoma treated with immunotherapy - development and validation of the CRAFITY score

enthalten in: Journal of hepatology | 2022

von Scheiner, B. | Pomej, K. | Kirstein, M. | +38

CommentIn: J Hepatol. 2022 Apr;76(4):987-988. - PMID 34780876